Novartis Czech Republic`s EBITDA reached 138 CZK mil in 2017. This is 18.9 % less than in the previous year.
Buy annual subscriptions for all our products.
| Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | CZK mil | ... | ... | ... | ... | ... | 58.3 | 37.3 | 41.1 | 54.4 | 46.3 | ||||||||
| Bayer Czech Republic | CZK mil | ... | ... | ... | 168 | 112 | 135 | 143 | 168 | ||||||||||
| GlaxoSmithKline Czech Republic | CZK mil | ... | ... | ... | 310 | 234 | 189 | 139 | 139 | ||||||||||
| Merck Czech Republic | CZK mil | ... | ... | 67.1 | 83.8 | 49.2 | 53.6 | 95.9 | |||||||||||
| Novartis Czech Republic | CZK mil | 61.6 | 69.8 | 71.6 | 113 | 131 | |||||||||||||
| Pfizer Czech Republic | CZK mil | ... | ... | 316 | 66.4 | 173 | 172 | 110 | |||||||||||
| Roche Czech Republic | CZK mil | ... | ... | ... | 208 | 204 | 328 | 265 | 209 | ... | |||||||||
| Sanofi-Aventis Czech Republic | CZK mil | ... | ... | ... | ... | 90.8 | 80.9 | 98.9 | 17.0 | 94.6 | |||||||||
| Servier Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 19.2 | 20.1 | 20.8 | 23.8 | ||
| Walmark | CZK mil | ... | ... | ... | 346 | 149 | 126 | 215 | -241 |
Helgi Library 
